SARS-COV-2
Conditions
Interventions
Observation group:None
Sponsors
Zhuhai People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years, no gender restriction; 2. Continuous use of Azvudine for >=2 days, or discontinuation due to adverse drug reactions after 1 day of use; 3. No restriction on the severity of kidney injury; 4. Routine blood tests and liver and kidney function tests before and after administration.
Exclusion criteria
Exclusion criteria: 1. Patients with malignant tumors; 2. Patients in the acute phase of neurological diseases; 3. Patients with decompensated liver cirrhosis; 4. Pregnant or breastfeeding patients;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Review and analyze the incidence of adverse reactions in patients after medication (including changes in liver and kidney function, myocardial enzyme indicators, blood routine, electrolytes, etc.; gastrointestinal adverse reactions, drug allergies, etc.); | — |
Countries
China
Contacts
Public ContactJiajian Qian
Zhuhai People's Hospital
Outcome results
None listed